Page 678 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

656 PART IV Specific Malignancies in the Small Animal Patient

93. Moroff SD, Brown BA, Matthiesen DT, et al.: Infiltrative urethral 117. McCleary-Wheeler AL, Williams LE, Hess PR, et al.: Evaluation of
disease in female dogs: 41 cases (1980-1987), J Am Vet Med Assoc an in vitro telomeric repeat amplification protocol assay to detect
199:247–251, 1991. telomerase activity in canine urine, Am J Vet Res 71:1468–1474,
VetBooks.ir 94. Bryan JN, Henry CJ, Turnquist SE, et al.: Primary renal neoplasia 118. Rankin WV, Henry CJ, Turnquist SE, et al.: Identification of sur-
2010.
of dogs, J Vet Intern Med 20:1155–1160, 2006.
95. Michael HT, Sharkey LC, Kovi RC, et al.: Pathology in practice.
renal nephroblastoma in a young dog, J Am Vet Med Assoc 242:471– vivin, an inhibitor of apoptosis, in canine urinary bladder transi-
tional cell carcinoma, Vet Comp Oncol 6:141–150, 2008.
473, 2013. 119. Lee J-Y, Tanabe S, Shimohira H, et al.: Expression of cyclooxygen-
96. Montinaro V, Boston SE, Stevens B: Renal nephroblastoma in a ase-2, P-glycoprotein and multi-drug resistance-associated protein
3-month-old golden retriever, Can Vet J 54:683–686, 2013. in canine transitional cell carcinoma, Res Vet Sci 83:210–216, 2007.
97. Klein MK, Campbell GC, Harris CK, et al.: Canine primary renal 120. Dill AL, Ifa DR, Manicke NE, et al.: Lipid profiles of canine inva-
neoplasms: a retrospective review of 54 cases, J Am Anim Hosp Assoc sive transitional cell carcinoma of the urinary bladder and adjacent
24:443–452, 1987. normal tissue by desorption electrospray ionization imaging mass
98. Lingaas F, Comstock KE, Kirkness EF, et al.: A mutation in the spectrometry, Anal Chem 81:8758–8764, 2009.
canine BHD gene is associated with hereditary multifocal renal 121. Hanazono K, Fukumoto S, Kawamura Y, et al.: Epidermal growth
cystadenocarcinoma and nodular dermatofibrosis in the German factor receptor expression in canine transitional cell carcinoma,
Shepherd dog, Hum Mol Genet 12:3043–3053, 2003. J Vet Med Sci 77:1–6, 2015.
99. Bønsdorff TB, Jansen JH, Thomassen RF, et al.: Loss of heterozy- 122. Hanazono K, Nishimori T, Fukumoto S, et al.: Immunohisto-
gosity at the FLCN locus in early renal cystic lesions in dogs with chemical expression of p63, Ki67 and β-catenin in canine transi-
renal cystadenocarcinoma and nodular dermatofibrosis, Mamm tional cell carcinoma and polypoid cystitis of the urinary bladder,
Genome 20:315–320, 2009. Vet Comp Oncol 14:263–269, 2016.
100. Grillo TP, Brandão CVS, Mamprim MJ, et al.: Hypertrophic oste- 123. Suárez-Bonnet A, Herráez P, Aguirre M, et al.: Expression of cell
opathy associated with renal pelvis transitional cell carcinoma in a cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine
dog, Can Vet J 48:745–747, 2007. transitional cell carcinoma of the urinary bladder, Urol Oncol
101. Froment R, Gara-Boivin C: Bilateral renal T-cell lymphoma with 33(7):332.e1–332.e7, 2015.
hepatic infiltration and secondary polycythemia in a dog: utility of 124. Dhawan D, Ramos-Vara JA, Stewart JC, et al.: Canine invasive
cytology slides, Can Vet J 56:1287–1291, 2015. transitional cell carcinoma cell lines: in vitro tools to complement
102. Durno AS, Webb JA, Gauthier MJ, et al.: Polycythemia and inap- a relevant animal model of invasive urinary bladder cancer, Urol
propriate erythropoietin concentrations in two dogs with renal Oncol 27:284–292, 2009.
T-cell lymphoma, J Am Anim Hosp Assoc 47:122–128, 2011. 125. Dhawan D, Ramos-Vara JA, Hahn NM, et al.: DNMT1: an
103. Petterino C, Luzio E, Baracchini L, et al.: Paraneoplastic leukocyto- emerging target in the treatment of invasive urinary bladder cancer,
sis in a dog with a renal carcinoma, Vet Clin Pathol 40:89–94, 2011. Urol Oncol 31:1761–1769, 2013.
104. Merrick CH, Schleis SE, Smith AN, et al.: Hypercalcemia of malig- 126. Dhawan D, Craig BA, Cheng L, et al.: Effects of short-term cele-
nancy associated with renal cell carcinoma in a dog, J Am Anim coxib treatment in patients with invasive transitional cell carcinoma
Hosp Assoc 49:385–388, 2013. of the urinary bladder, Mol Cancer Ther 9:1371–1377, 2010.
105. Gil da Costa RM, Oliveira JP, Saraiva AL, et al.: Immunohisto- 127. Dhawan D, Paoloni M, Shukradas S, et al.: Comparative gene
chemical characterization of 13 canine renal cell carcinomas, Vet expression analyses identify luminal and basal subtypes of canine
Pathol 48:427–432, 2011. invasive urothelial carcinoma that mimic patterns in human inva-
106. Edmondson EF, Hess AM, Powers BE: Prognostic significance of sive bladder cancer. St-Pierre Y, PLoS One 10:e0136688, 2015.
histologic features in canine renal cell carcinomas: 70 nephrecto- 128. Ramsey SA, Xu T, Goodall C, et al.: Cross-species analysis of the
mies, Vet Pathol 52:260–268, 2015. canine and human bladder cancer transcriptome and exome, Genes
107. Carvalho S, Stoll AL, Priestnall SL, et al.: Retrospective evaluation Chromosomes Cancer 56:328–343, 2017.
of COX-2 expression, histological and clinical factors as prognostic 129. Khan KN, Knapp DW, Denicola DB, et al.: Expression of cyclo-
indicators in dogs with renal cell carcinomas undergoing nephrec- oxygenase-2 in transitional cell carcinoma of the urinary bladder in
tomy, Vet Comp Oncol 15:1280–1294, 2017. dogs, Am J Vet Res 61:478–481, 2000.
108. Henry CJ, Turnquist SE, Smith A, et al.: Primary renal tumours in 130. Cekanova M, Uddin MJ, Bartges JW, et al.: Molecular imaging of
cats: 19 cases (1992-1998), J Feline Med Surg 1:165–170, 1999. cyclooxygenase-2 in canine transitional cell carcinomas in vitro and
109. Gulbahar MY, Arslan HH, Gacar A, et al.: Sarcomatoid renal cell in vivo, Cancer Prev Res (Phila) 6:466–476, 2013.
carcinoma with scant epithelial components in an Angora cat, N Z 131. Sledge DG, Patrick DJ, Fitzgerald SD, et al.: Differences in expres-
Vet J 61:362–366, 2013. sion of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine
110. Johnson RL, Lenz SD: Hypertrophic osteopathy associated with a proliferative urothelial lesions of the urinary bladder, Vet Pathol
renal adenoma in a cat, J Vet Diagn Invest 23:171–175, 2011. 52:74–82, 2015.
111. Gómez Selgas A, Scase TJ, Foale RD: Unilateral squamous cell car- 132. Millanta F, Impellizeri J, McSherry L, et al.: Overexpression of
cinoma of the renal pelvis with hydronephrosis in a cat, J Feline HER-2 via immunohistochemistry in canine urinary bladder
Med Surg 16:183–188, 2014. transitional cell carcinoma - a marker of malignancy and possible
112. Hanzlicek AS, Ganta C, Myers CB, et al.: Renal transitional-cell therapeutic target, Vet Comp Oncol, 2017. https://doi.org/10.1111/
carcinoma in two cats with chronic kidney disease, J Feline Med vco.12345. Epub ahead of print.
Surg 14:280–284, 2012. 133. Cancer Genome Atlas Research Network JN, Akbani R, Broom
113. Evans D, Fowlkes N: Renal leiomyosarcoma in a cat, J Vet Diagn BM, et al.: Comprehensive molecular characterization of urothelial
Invest 28:315–318, 2016. bladder carcinoma, Nature 507:315–322, 2014.
114. Bonsembiante F, Benali SL, Trez D, et al.: Histological and immu- 134. Choi W, Ochoa A, McConkey DJ, et al.: Genetic alterations in the
nohistochemical characterization of feline renal cell carcinoma: a molecular subtypes of bladder cancer: illustration in The Cancer
case series, J Vet Med Sci 78:1039–1043, 2016. Genome Atlas Dataset, Eur Urol 72:354–365, 2017.
115. Klainbart S, Segev G, Loeb E, et al.: Resolution of renal adeno- 135. Sánchez-Gastaldo A, Kempf E, González Del Alba A, et al.: Sys-
carcinoma-induced secondary inappropriate polycythaemia after temic treatment of renal cell cancer: a comprehensive review, Can-
nephrectomy in two cats, J Feline Med Surg 10:264–268, 2008. cer Treat Rev 60:77–89, 2017.
116. Czerniak B, Dinney C, McConkey D: Origins of bladder cancer, 136. Chow W-H, Dong LM, Devesa SS: Epidemiology and risk factors
Annu Rev Pathol 11:149–174, 2016. for kidney cancer, Nat Rev Urol 7:245–257, 2010.